Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155408 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Waleed Hassan Almalki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Electronic address: Whmalki@uqu.edu.sa. Hauptthemen laut MEDLINE: RNA, Circular, Neoplasms, Signal Transduction, STAT Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 151 Literaturangaben.
Abstract (Originalsprache)
Circular RNAs, known as circRNAs, have drawn more attention to cancer biology in the last few years. Novel functions of circRNAs in cancer therapy open promising prospects for personalized medicine. This review focuses on the molecular properties and potential of circRNAs as biomarkers or therapeutic targets in cancer treatment. Unique properties of circular RNAs associated with a circular form provide stability and resilience to RNA exonuclease degradation. Circular RNAs' most important characteristic is that they are involved in the JAK/STAT pathway associated with oncogenesis. Notably, their deregulation has been reported in multiple carcinomas due to involvement in JAK/STAT signaling cascade modulation. Increased knowledge about circRNAs' interaction with the JAK/STAT pathway leads to the emergence of new possibilities for targeted cancer therapy. In addition, since circRNAs demonstrate tissue-relatedness of expression, they may be a reliable biomarker for predicting and diagnosing cancer. With the development of new technologies for targeting circRNAs, novel therapeutics can be produced that offer more personalized cancer treatment options based on the nature of the patient. The present review explores the exciting prospects of circRNAs for transforming cancer treatment into personalized medicine. It describes the current understanding of circRNA biology, its relationship to tumorigenesis, and possible targeting methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Electronic address: Whmalki@uqu.edu.sa.
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Aseer 61421, Saudi Arabia.
Zitieren
APA
Almalki, W. H., & Almujri, S. S. (2024). Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155408
Vancouver
Almalki WH, Almujri SS. Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155408
BibTeX
@article{Almalki2024,
author = {Almalki, Waleed Hassan and Almujri, Salem Salman},
title = {Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155408}
}
EUVIMED